Lansing Street Advisors’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Lansing Street Advisors's PGEN Position: Q2 2026 in Review
Lansing Street Advisors reduced its Precigen (PGEN) stake by 11% in Q2 2026, selling an estimated $252K and leaving 495,422 shares worth $2.82M. The position accounts for 0.6% of the portfolio, ranked #34.
Lansing Street Advisors first reported a position in PGEN in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Lansing Street Advisors held 495,422 shares of Precigen worth $2.82M as of Q2 2026.
- Lansing Street Advisors sold 58,241 Precigen shares in Q2 2026, an estimated $252K.
- Precigen made up 0.6% of Lansing Street Advisors's portfolio in Q2 2026, its #34 holding.
- Lansing Street Advisors first reported a position in Precigen in Q3 2025 and has held it in 4 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Lansing Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.